Filament Health Corp. (FLHLF) is a publicly traded company in the Healthcare sector, operating within the Drug Manufacturers - Specialty & Generic industry. The company is headquartered in Burnaby, BC, Canada. The current CEO is Benjamin Lightburn.
FLHLF has IPO date of 2021-09-03, 13 full-time employees, listed on the Other OTC, a market capitalization of $26.18K.
Filament Health Corp. operates as a natural psychedelic drug discovery and extraction technology company. It propagates psychedelic plants; conducts genetic research; performs extraction procedures; runs in-house trials; and distributes IP and drug candidates to drug developers, researchers, and other licensed parties. The company is headquartered in Vancouver, Canada.
